title: Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis.
abstract: We report a case of visceral leishmaniasis in a patient from northern Norway with psoriatic arthritis treated with a combination of etanercept and methotrexate. The patient resided extensively in southern Spain, a zone endemic for leishmania.
authors.affiliation: University North Norway, Tromsö, Norway, emilio.besada@unn.no.
authors.forename: Emilio
authors.initials: E
authors.lastname: Besada
authors.forename: Rune Johan
authors.initials: RJ
authors.lastname: Njålla
authors.forename: Johannes C
authors.initials: JC
authors.lastname: Nossent
mesh_terms: D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000150:complications / Q000188:drug therapy*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use*; D009664:Norway; D010198:Pancytopenia / Q000209:etiology*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D013030:Spain; D016896:Treatment Outcome
chemical_list: D000981:Antiprotozoal Agents; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; C068538:liposomal amphotericin B; D000666:Amphotericin B; D000068800:Etanercept; D008727:Methotrexate